Effect of long-term hormone replacement therapy on the bone in ovariectomized women with cancer

International Journal of Gynecology and Obstetrics

Volumn 60, Issue 3, 1998, Pages 271-277

  Kurabayashi, T ^a   Yahata, T ^a   Honda, A ^a   Tomita, M ^a   Yasuda, M ^a   Tanaka, T ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Bone mineral density; Gynecologic malignancy; Hormone replacement therapy; Osteoporosis; Ovariectomy

Indexed keywords

ALKALINE PHOSPHATASE; CONJUGATED ESTROGEN; MEDROXYPROGESTERONE ACETATE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; FEMALE; GYNECOLOGIC CANCER; HORMONE SUBSTITUTION; HUMAN; LONGITUDINAL STUDY; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; OVARIECTOMY; PREMENOPAUSE; PRIORITY JOURNAL;

EID: 0032030514     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(97)00272-5     Document Type: Article

References (20)

1. [1] Aitken JM, Hart DM, Lindsay R. Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy. Br Med J 1973;3:515-518.
2. [2] Christiansen C, Christiansen MS, Transbol I. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet 1981; 1:459-461.
3. [3] Genant HK, Baylink DJ, Gallagher JC. Estrogens in the prevention of osteoporosis in post menopausal women. Am J Obstet Gynecol 1989;161:1842-1846.
4. [4] Genant HK, Cann CE, Ettinger B, Gordan GS. Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med 1982;97:699-705.
5. [5] Lindsay R, Hart DM, Forrest C, Baird C. Prevention of spinal osteoporosis in oophorectomized women. Lancet 1980;2:1151-1154.
6. [6] Yasuda M, Kurabayashi T, Yamamoto Y, Fujimaki T, Oda K, Tanaka K. Effect of hormone replacement therapy on bone and lipid metabolism in women oophorectomized for the treatment of gynecologic malignancies. Int J Gynecol Obstet 1994;47:151-156.
7. [7] Creasman WT, Henderson D, Hinshaw W, Clarke-Pearson BL. Estrogen replacement therapy in the patient treated for endometrial cancer. Obstet Gynecol 1986;67:326-330.
8. [8] Lee RB, Burke TW, Park RC. Estrogen replacement therapy following treatment for stage I endometrial cancer. Gynecol Oncol 1990;36:189-191.
9. [9] Creasman WT. Estrogen replacement therapy: is previously treated cancer a contra-indication? Obstet Gynecol 1991;77:308-312.
10. [10] Gitsch G, Hanzal E, Jensen D, Hacker NF. Endometrial cancer in premenopausal women 45 years and younger. Obstet Gynecol 1995;85:504-508.
11. [11] Aalders JG, Abeler V, Kolstad P. Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients. Gynecol Oncol 1984;17:85-103.
12. [12] Morrison JC, Martin DC, Blair RA, Anderson GD, Kincheloe BW, Bates GW, Hendrix JW, Rivlin ME, Forman EK, Propst MG, Needham R. The use of medroxyprogesterone acetate for relief of climacteric syndrome. Am J Obstet Gynecol 1980;138:99-104.
13. [13] Prior JC. Progesterone as a bone trophic hormone. Endocr Rev 1990;11:386-398.
14. [14] Wren B. Hormonal therapy and genital tract cancer. Curr Opin Obstet Gynecol 1996;8:38-41.
15. [15] Stanford JL, Thomas DB, Ray RM, Noonan EA. Epithelial ovarian cancer and combined oral contraceptives: the WHO collaborative study of neoplasia and steroid contraceptives. Int J Epidemiol 1989;18:538-545.
16. [16] Hartge P, Schiffman MN, Hoover R, McGowan L, Lesher L, Norris HJ. A case control study of epithelial ovarian cancer. Am J Obstet Gynecol 1989;161:10-16.
17. [17] Shoham Z. Epidemiology, aetiology and fertility drugs in epithelial carcinoma: where are we today? Fertil Steril 1994;62:433-448.
18. [18] Rodriguez C, Calle EE, Coates RJ, Miracle-McMahill HL, Thun MJ, Heath CW. Estrogen replacement therapy and fetal ovarian cancer. Am J Epidemiol 1995;141:828-835.
19. [19] Speroff L, Glass RH, Kase NG. Clin Gynecol Endocrinol and Infertil. 4th ed. Baltimore: Williams and Wilkins, 1994.
20. [20] Eifel PJ, Morris M, Oswald MJ, Wharton JT, Delclos L. Adenocarcinoma of the uterine cervix. Prognosis and patterns of failure in 367 cases. Cancer 1990; 65:2507-2514.